For Pharmaceutical and Life Sciences

Cognitive Sovereignty Self-Audit for Pharmaceutical and Life Sciences

This audit measures whether your organisation can still make independent scientific judgements when using AI tools like Schrödinger, Insilico Medicine, and BenevolentAI. A high score means your researchers retain critical thinking about AI outputs. A low score suggests AI recommendations may be replacing human expertise rather than supporting it.

This takes about two minutes. Answer honestly.

Download printable PDF

1. When Schrödinger AI ranks lead compounds for your drug discovery programme, how do your chemists respond?

2. Your clinical trial protocol was partly designed by AI optimisation software. When a regulatory reviewer questions the chosen endpoints, what happens?

3. Your researchers use IBM Watson Health or ChatGPT to draft sections of your regulatory dossier. How do you manage this work before submission?

4. A junior researcher joins your team with strong AI skills but limited foundational chemistry or biology training. How do you manage their role in drug discovery?

5. BenevolentAI identifies a novel drug target for your indication. How does your team evaluate this recommendation?

6. One of your AI-driven clinical trial designs shows high statistical power but includes endpoints your medical advisors find clinically weak. What do you do?

7. Your researchers increasingly use generative AI to write methods sections in lab protocols. How often do senior scientists independently verify that these methods are actually feasible in your lab?

8. When you receive a regulatory rejection based on AI-heavy analysis from your team, how does your organisation respond?

Your score

Read Chapter 1 Free

Keep in mind

Related reads

The Book — Out Now

Cognitive Sovereignty: How To Think For Yourself When AI Thinks For You

Read the first chapter free.

No spam. Unsubscribe anytime.